Work

Thrombo-inflammation in Cardiometabolic Disease

Year: 2026

Type: article

Abstract: Cardiometabolic disorders like obesity and diabetes are closely linked with activated coagulation and inflammatory and immune signalling, leading to increased risk of thromboembolism and stroke. In this review, we elaborate recent clinical and basic science insights into the causal and bidirectional links between thrombo-inflammation-settings of activated coagulation and inflammation-and cardiometabolic disease. We discuss how metabolic disorders provide early triggers for a procoagulant state, notably endothelial dysfunction, platelet hyper-reactivity and an imbalance between procoagulant and fibrinolytic signals, and how the interplay with inflammation and immune signalling affects cardiac and adipose tissues and ultimately clinical outcome. We discuss possible sex differences and highlight candidate biomarker signatures that could improve timely detection of thrombo-inflammation, and review the recent evidence and remaining challenges of currently available therapeutic strategies.

Source: Canadian Journal of Cardiology

DOI: 10.1016/j.cjca.2026.03.046

Authors: Anke C. Fender, Dobromir Dobrev

Institutions: University of Duisburg-Essen, Baylor College of Medicine, Montreal Heart Institute, Université de Montréal

Language: English

Topic: Blood Coagulation and Thrombosis Mechanisms

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: hybrid

Estimated APC paid: $3,710